Braintale develops and distributes diagnosis and prognosis tools for brain injured patients.
Braintale has raised $4.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2023.
Braintale's investors include Bpifrance, AGORANOV, MACSF, Capital Grand Est, Paris Business Angels.
Braintale is headquartered in Paris, France.
Braintale develops and distributes diagnosis and prognosis tools for brain injured patients.
Braintale is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Braintale — Funding & Investors." VCBacked, June 20, 2023, https://www.vcbacked.co/company/braintale. Accessed October 11, 2026.
VCBacked. (2023). Braintale — Funding & Investors. Retrieved October 11, 2026, from https://www.vcbacked.co/company/braintale
{{cite web |title=Braintale — Funding & Investors |url=https://www.vcbacked.co/company/braintale |website=VCBacked |access-date=October 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated